Gilead to Licese Generic Viread to Companies in India

Gilead Sciences (GILD) announced that it had signed a licensing agreement with eight pharmaceutical companies in India to market a generic version of Viread to ninety-five low income countries around the world.

The eight indian companies are;

Alkem Laboratories Ltd.
Aurobindo Pharma Ltd.
FDC Ltd.
J.B. Chemicals & Pharmaceuticals Ltd.
Matrix Laboratories Ltd.
Medchem International
Ranbaxy Laboratories
Shasun Chemicals & Drugs Ltd

This follows a similar agreement Gilead entered into in August with other Indian companies; Emcure Pharmaceuticals, Hetero Drugs, and Strides Arcolab.

This is a smart move by Gilead to control the generic development of Viread while also improving the image of the company by helping out developing nations.

_